USPTO serial 97109553
PREVAILONE
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- HAUENSTEIN, HOLLAND LESLEY
- Law office
- TMO LAW OFFICE 302- EXAMINING ATTORNEY ASSIGNED
What this means
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
Need help with PREVAILONE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Newport Beach, CA
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Sandra Gibbs
SANDRA GIBBS MULCAHY LLP4 PARK PLAZA, SUITE 1950IRVINE, CA 92614UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 035 | Providing medical and prescription benefit and support services to patients, providers, and manufacturers of drugs, devices, pharmaceuticals, medicines, biologics, and therapies; advising and providing information to patients, providers, and manufacturers of drugs, devices, pharmaceuticals, medicines, biologics, and therapies in the fields of health care, medical and prescription insurance benefits, medical and prescription insurance coverage, financial programs, cost management, and payment options; business services provided to manufacturers of drugs, devices, pharmaceuticals, medicines, biologics, and therapies, namely, collecting, organizing, categorizing, managing, interpreting, analyzing, storing, aggregating, de-identifying, and reporting of health care information, patient data, health care quality and cost data, and coverage and benefit data for business purposes; medical and prescription benefit and patient support hub services, namely, determining and communicating medical and prescription benefit information, determining and communicating medical and prescription benefit and insurance coverage and reimbursement investigation and verification, obtaining patient authorization and consent and physician attestation with respect to performance of services and disclosure of information, providing prior authorization support, claims and appeals support, payer policy research, prescription access and delivery administration and support, copay support, eligibility determination, and enrollment, financial assistance, patient assistance, and free drug program support, eligibility determination, and enrollment, and patient education and support, for patients, providers, pharmacies, and manufacturers of drugs, devices, pharmaceuticals, medicines, biologics, and therapies; electronic medical and prescription benefit and support services to patients, providers, and manufacturers of drugs, devices, pharmaceuticals, medicines, biologics, and therapies; electronic advising and providing information to patients, providers, and manufacturers of drugs, devices, pharmaceuticals, medicines, biologics, and therapies in the fields of health care, medical and prescription insurance benefits, medical and prescription insurance coverage, financial programs, cost management, and payment options; electronic business services provided to manufacturers of drugs, devices, pharmaceuticals, medicines, biologics, and therapies, namely, collecting, organizing, categorizing, managing, interpreting, analyzing, storing, aggregating, de-identifying, and reporting of health care information, patient data, health care quality and cost data, and coverage and benefit data for business purposes; electronic medical and prescription benefit and patient support hub services, namely, determining and communicating medical and prescription benefit information, determining and communicating medical and prescription benefit and insurance coverage and reimbursement investigation and verification, obtaining patient authorization and consent and physician attestation with respect to performance of services and disclosure of information, providing prior authorization support, claims and appeals support, payer policy research, prescription access and delivery administration and support, copay support, eligibility determination, and enrollment, financial assistance, patient assistance, and free drug program support, eligibility determination, and enrollment, and patient education and support, for patients, providers, pharmacies, and manufacturers of drugs, devices, pharmaceuticals, medicines, biologics, and therapies | ACTIVE | Sep 2, 2021 |
| 036 | Providing warranties for drugs, pharmaceuticals, medicines, biologics, and therapies; administering and managing health care reinsurance programs, claims, and processing; reinsurance services, namely, underwriting, rating, and administering health care reinsurance programs; design and development of health care reinsurance agreements; health care reinsurance services for drugs, pharmaceuticals, medicines, and therapies | ACTIVE | Sep 2, 2021 |
| 042 | Software as a service (SaaS) services featuring software for medical and prescription benefit and support services to patients, providers, and manufacturers of drugs, devices, pharmaceuticals, medicines, biologics, and therapies; providing online non-downloadable software for medical and prescription benefit and support services to patients, providers, and manufacturers of drugs, devices, pharmaceuticals, medicines, biologics, and therapies; software as a service (SaaS) services featuring software for advising and providing information to patients, providers, and manufacturers of drugs, devices, pharmaceuticals, medicines, biologics, and therapies in the fields of health care, medical and prescription insurance benefits, medical and prescription insurance coverage, financial programs, cost management, and payment options; providing online non-downloadable software for advising and providing information to patients, providers, and manufacturers of drugs, devices, pharmaceuticals, medicines, biologics, and therapies in the fields of health care, medical and prescription insurance benefits, medical and prescription insurance coverage, financial programs, cost management, and payment options; software as a service (SaaS) services featuring software for patient support services for health and medical case management; providing online non-downloadable software for use in patient support services for health and medical case management; software as a service (SaaS) services featuring software for business services provided to manufacturers of drugs, devices, pharmaceuticals, medicines, biologics, and therapies, namely, collecting, organizing, categorizing, managing, interpreting, analyzing, storing, aggregating, de-identifying, and reporting of health care information, patient data, health care quality and cost data, and coverage and benefit data for business purposes; providing online non-downloadable software for business services provided to manufacturers of drugs, devices, pharmaceuticals, medicines, biologics, and therapies, namely, collecting, organizing, categorizing, managing, interpreting, analyzing, storing, aggregating, de-identifying, and reporting of health care information, patient data, health care quality and cost data, and coverage and benefit data for business purposes; software as a service (SaaS) services featuring software for medical and prescription benefit and patient support hub services, namely, determining and communicating medical and prescription benefit information, determining and communicating medical and prescription benefit and insurance coverage and reimbursement investigation and verification, obtaining patient authorization and consent and physician attestation with respect to performance of services and disclosure of information, providing prior authorization support, claims and appeals support, payer policy research, prescription access and delivery administration and support, copay support, eligibility determination, and enrollment, financial assistance, patient assistance, and free drug program support, eligibility determination, and enrollment, and patient education and support, for patients, providers, pharmacies, and manufacturers of drugs, devices, pharmaceuticals, medicines, biologics, and therapies; providing online non-downloadable software for medical and prescription benefit and patient support hub services, namely, determining and communicating medical and prescription benefit information, determining and communicating medical and prescription benefit and insurance coverage and reimbursement investigation and verification, obtaining patient authorization and consent and physician attestation with respect to performance of services and disclosure of information, providing prior authorization support, claims and appeals support, payer policy research, prescription access and delivery administration and support, copay support, eligibility determination, and enrollment, financial assistance, patient assistance, and free drug program support, eligibility determination, and enrollment, and patient education and support, for patients, providers, pharmacies, and manufacturers of drugs, devices, pharmaceuticals, medicines, biologics, and therapies; software as a service (SaaS) services featuring software for customer relationship management; providing online non-downloadable software for customer relationship management; providing application programming interface (API) gateways to enable users, partners, vendors, patients, providers and manufacturers of drugs, devices, pharmaceuticals, medicines, biologics, and therapies to access and interact with software applications for providing medical and prescription benefit and support services; providing application programming interface (API) gateways to enable users, partners, vendors, patients, providers and manufacturers of drugs, devices, pharmaceuticals, medicines, biologics, and therapies to access and interact with software applications for advising and providing information in the fields of health care, medical and prescription insurance benefits, medical and prescription insurance coverage, financial programs, cost management, and payment options; providing application programming interface (API) gateways to enable users, partners, vendors, patients, providers and manufacturers of drugs, devices, pharmaceuticals, medicines, biologics, and therapies to access and interact with software applications for providing patient support services for health and medical case management; providing application programming interface (API) gateways to enable users, partners, vendors, patients, providers and manufacturers of drugs, devices, pharmaceuticals, medicines, biologics, and therapies to access and interact with software applications for providing business services, namely, collecting, organizing, categorizing, managing, interpreting, analyzing, storing, aggregating, de-identifying, and reporting of health care information, patient data, health care quality and cost data, and coverage and benefit data for business purposes; providing application programming interface (API) gateways to enable users, partners, vendors, patients, providers and manufacturers of drugs, devices, pharmaceuticals, medicines, biologics, and therapies to access and interact with software applications for providing medical and prescription benefit and patient support hub services, namely, determining and communicating medical and prescription benefit information, determining and communicating medical and prescription benefit and insurance coverage and reimbursement investigation and verification, obtaining patient authorization and consent and physician attestation with respect to performance of services and disclosure of information, providing prior authorization support, claims and appeals support, payer policy research, prescription access and delivery administration and support, copay support, eligibility determination, and enrollment, financial assistance, patient assistance, and free drug program support, eligibility determination, and enrollment, and patient education and support, for patients, providers, pharmacies, and manufacturers of drugs, devices, pharmaceuticals, medicines, biologics, and therapies | ACTIVE | — |
| 044 | Patient support services for health and medical case management; electronic patient support services in health and medical case management | ACTIVE | Sep 2, 2021 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 2, 2022 | MAB2 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Aug 2, 2022 | MAB2 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Aug 2, 2022 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Jan 18, 2022 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 18, 2022 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 18, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 12, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 15, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Nov 8, 2021 | NWAP | NEW APPLICATION ENTERED | — |